Shots:In this episode of the CXO Talks podcast, PharmaShots speaks with Rick Modi, CEO at Affinia TherapeuticsDriven by cutting-edge innovation, Affinia is pioneering and re-imagining adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method for conditions affecting cardiac muscle, skeletal muscle, and the central nervous systemRick articulates the diagnostic and therapeutic…
